Clinical Research Directory
Browse clinical research sites, groups, and studies.
Carotid Revascularization With MicroNet Covered Stent Comparing Early Neurological Outcomes With Distal Versus Proximal EPS
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Summary
The SIBERIA study demonstrated a clear advantage of CGuard stent implantation over the existing classical stent when using a distal anti-embolic device. At the same time, there is no Level 1 evidence for a difference between the proximal and distal anti-embolic device for the CGuard stent.
Official title: Independent Randomized Clinical Trial in Carotid Revascularization With MicroNet Covered Stent (CGuard) Comparing Early Neurological Outcomes With Distal EPS Versus Proximal EPS
Key Details
Gender
All
Age Range
45 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
366
Start Date
2021-11-01
Completion Date
2027-01-01
Last Updated
2022-02-25
Healthy Volunteers
No
Conditions
Interventions
Emboshield NAV6™
Embolic Protection System for Carotid Artery Revascularization ( distal - filter) + stent CGuardTM™
Mo.Ma™
Embolic Protection System for Carotid Artery Revascularization ( proximal - occlusion) + stent CGuardTM™
Locations (1)
E. Meshalkin National Medical Research Center
Novosibirsk, Russia